NYSEARCA:KURE KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News $16.02 +0.10 (+0.60%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KURE alerts:Sign Up Key Stats Today's Range$16.00▼$16.1550-Day Range$13.39▼$16.0052-Week Range$12.91▼$20.51Volume11,069 shsAverage Volume42,718 shsMarket Capitalization$85.68 millionAssets Under Management$83.84 millionDividend Yield1.12%Net Expense Ratio0.65%Aggregate RatingModerate Buy ETF OverviewThe KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.Read More… KraneShares MSCI All China Health Care Index ETF ExpensesTypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.78%0.57%0.57%0.52%0.53%Other Expenses0.01%0.30%0.48%0.56%0.51%Total Expense0.79%0.70%0.72%0.73%0.71%Fee Waiver-0.14%-0.45%-0.49%-0.65%-0.54%Net Expense0.65%0.61%0.63%0.58%0.60% Receive KURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address KURE ETF News HeadlinesNew Drivers For China Health Care: AI Med-Tech Innovation, Cancer Treatment, And Favorable Balance Of TradeMarch 18, 2025 | seekingalpha.comKraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) Dividend HistoryMarch 2, 2025 | nasdaq.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. May 21, 2025 | Golden Portfolio (Ad)China Market Update: The Tale Of Two China’s & Their Investors Returns!November 11, 2024 | forbes.comAmundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)October 8, 2024 | investing.comKURE KraneShares MSCI All China Health Care Index ETFSeptember 21, 2024 | seekingalpha.comSee More Headlines KURE ETF - Frequently Asked Questions How have KURE shares performed this year? KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the start of the year. Since then, KURE stock has increased by 12.9% and is now trading at $16.0150. View the best growth stocks for 2025 here. Who are KraneShares MSCI All China Health Care Index ETF's major shareholders? KraneShares MSCI All China Health Care Index ETF's top institutional investors include OLD Mission Capital LLC (3.65%) and Jane Street Group LLC (1.27%). How do I buy shares of KraneShares MSCI All China Health Care Index ETF? Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KraneShares MSCI All China Health Care Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA). Fund Details IssuerKraneShares Fund NameKraneShares MSCI All China Health Care Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:KURE Inception Date1/31/2018 Fund ManagerMark Schlarbaum WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI China All Shares Health Care 10/40 Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings54 Fund Statistics Assets Under Management$83.84 million Average Daily Volume$18,668.70 Discount/Premium0.10% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorKrane Funds Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest7,100 shs Miscellaneous Outstanding Shares5,350,000Beta0.20 Creation Unit50,000 Creation Fee$1,320.00 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report Top 10 KURE HoldingsJiangsu Hengrui Medicine Co., Ltd.Holding Weight: 8.34%BeiGene, Ltd.Holding Weight: 8.22%Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Holding Weight: 6.80%WuXi Biologics (Cayman) Inc.Holding Weight: 6.37%Innovent Biologics, Inc.Holding Weight: 5.45%Akeso, Inc.Holding Weight: 4.47%CSPC Pharmaceutical Group LimitedHolding Weight: 4.05%WuXi AppTec Co., Ltd.Holding Weight: 3.78%Sino Biopharmaceutical LimitedHolding Weight: 3.32%Zhangzhou Pientzehuang Pharmaceutical., LtdHolding Weight: 3.25%Full Holdings DetailsKURE Sector ExposureKURE Industry Exposure This page (NYSEARCA:KURE) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KraneShares MSCI All China Health Care Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share KraneShares MSCI All China Health Care Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.